Our results support this idea by showing that the addition of exogenous purified Gal-1 boosts H-1PV infection at the level of virus entry, thereby sensitising semi-permissive cancer cells to H-1PV-mediated oncolysis. This evidence concerns the gene LGALS1 and infection.